<p>CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered inflamma
<p>When IPO activity is high, it is generally interpreted as an indication of investor and corporate confidence. A sluggish IPO market, on the other hand, can raise concerns and elicit inquiry a
Leave a Comment